Needham & Company raised its price target on Heron Therapeutics (NASDAQ: HRTX) to $66.00 (from $42.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE